Mount Sinai’s pharmacy goes ‘digital-first’
Mount Sinai goes digital-first with Latent and decreases time to medication access while freeing up staff to do more patient-facing work. In just a month, the Pharmacy team has cut completion time by at least 50%, with the team targeting a 75% to 80% reduction.
We can't hire 200 people within a month, which is what we would need for the thousands of prescriptions that we're receiving, like the GLP-1s. We wouldn't be able to meet it just as humans.
Vita SchwirianDirector of Outpatient Clinical Pharmacy ServicesPrior authorization completion time
Speed becomes capacity
- First monthAt least 50%
- Target75% to 80%
Sources: Becker’s Hospital Review, December 2, 2025. Mount Sinai Health System, 2026.
One axis from no reduction to a full reduction. A bar fills to at least 50% in the first month. A band marks the 75% to 80% target. A pin lands inside the band at about 75%.
With Latent, prior authorization completion time dropped by about 75%, from an average of 25 to 30 minutes to under 5.
Case study
Mount Sinai: harnessing demand and complexity to grow with AI
How Mount Sinai Health System used enterprise pharmacy intelligence to absorb a GLP-1 surge, win more complex cases, serve more patients and give pharmacists their time back to focus on care.
- Year-over-year prescription volume growth absorbed without adding staff
- 15-20%
- Average prior authorization completion time, down from 25–30
- <5 min
- From decision to full enterprise pharmacy intelligence implementation
- 1 day
About Latent Health
Latent is the enterprise pharmacy intelligence platform, powered by a clinical agentic engine, that enables health systems to grow their pharmacy operations and serve more patients. One engine works across the pharmacy journey to identify patients who qualify for care, improve medication access, capture eligible prescriptions and support patients throughout treatment. Latent’s platform enables more than 60 leading health systems that collectively serve an estimated 70 million people. Founded by Sriram “Sri” Somasundaram and Rishabh Jain, Latent has raised $80 million from Transformation Capital, Spark Capital, Conviction, General Catalyst, Y Combinator, and others. Learn more at latenthealth.com.
For media-related inquiries, please contact press@latent.com.